Robotic hip and knee replacement show no overall revision difference; FDA clears implant for screw loosening; Medicare add-on starts for P-15 graft

A metal bone plate with a row of screw holes and three seated screws, with a loose screw and a screwdriver beside it.

Two National Joint Registry studies published Sept. 30 in The BMJ found no difference in overall revision risk between robotic and conventional knee or hip replacement. The Food and Drug Administration (FDA) cleared an implant aimed at screw loosening in fusion constructs, and a Medicare add-on payment for a peptide bone graft used in lumbar fusion took effect Oct. 1.

The weekly innovation roundup for orthopedic surgery, published every Sunday for the week before; every item links to its sources. Latest orthopedic surgery news · All specialties

Latest news

Tagged orthopedic surgery, from the daily briefing

  1. Aspirin fails to prove noninferior to rivaroxaban or warfarin for clot prevention after hip or knee replacement in an 18,883-patient trial
  2. FDA approves pimicotinib for symptomatic tenosynovial giant cell tumor
  3. FDA approves pimicotinib (Pimjetmi) for tenosynovial giant cell tumor when surgery could worsen joint function

See all the latest news